Initially, four thyroid cancer cell lines were employed: TCO1, SW1736, and C643, which all harbor TERT c.-124C>T mutation, and Cal62, which was used as a control for a wild-type TERT promoter. Here, TERT is linked to thyroid gland carcinoma.